[Pharmacological treatment of sexual dysfunction in women]

Ugeskr Laeger. 2002 Oct 7;164(41):4794-6.
[Article in Danish]
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / therapeutic use
  • Alprostadil / adverse effects
  • Alprostadil / therapeutic use
  • Apomorphine / adverse effects
  • Apomorphine / therapeutic use
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / therapeutic use
  • Female
  • Humans
  • Phentolamine / adverse effects
  • Phentolamine / therapeutic use
  • Phosphodiesterase Inhibitors / adverse effects
  • Phosphodiesterase Inhibitors / therapeutic use
  • Sexual Dysfunction, Physiological / drug therapy*
  • Sexual Dysfunctions, Psychological / drug therapy*
  • Vasodilator Agents / adverse effects
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Dopamine Agonists
  • Phosphodiesterase Inhibitors
  • Vasodilator Agents
  • Alprostadil
  • Apomorphine
  • Phentolamine